[Phase I clinical study of 21-consecutive-day oral administration of etoposide].
Noda K, Fukuoka M, Komatsu H, Hayashihara K, Ariyoshi Y, Tanaka K, Nakajima H, Terashima Y, Nagao K, Furuse K, et al.
Noda K, et al. Among authors: nakajima h.
Gan To Kagaku Ryoho. 1994 Aug;21(10):1633-9.
Gan To Kagaku Ryoho. 1994.
PMID: 8060139
Clinical Trial.
Japanese.